<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32(3)</volume><submitter>Liu X</submitter><pubmed_abstract>Recombinant adeno-associated virus (rAAV)-based gene therapies are expanding in their application. Despite progress in manufacturing, current analytical methods for product quantification and characterization remain largely unchanged. Although critical for product and process development, in-process testing, and batch release, current analytical methods are labor-intensive, costly, and hampered by extended turnaround times and low throughput. The field requires more efficient, cost-effective analytical techniques capable of handling large sample quantities to accelerate product and process development. Here, we evaluated Stunner from Unchained Labs for quantifying and characterizing rAAVs and compared it with established analytical methods. Stunner is a combinatorial analytic technology pl</pubmed_abstract><journal>Molecular therapy. Methods &amp; clinical development</journal><pagination>101298</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11338085</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of a rapid multi-attribute combinatorial high-throughput UV-Vis/DLS/SLS analytical platform for rAAV quantification and characterization.</pubmed_title><pmcid>PMC11338085</pmcid><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Cai C</pubmed_authors><pubmed_authors>Jean-Gilles R</pubmed_authors><pubmed_authors>Davidson BL</pubmed_authors><pubmed_authors>Lance K</pubmed_authors><pubmed_authors>Yan R</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Baginski J</pubmed_authors><pubmed_authors>van der Loo JCM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of a rapid multi-attribute combinatorial high-throughput UV-Vis/DLS/SLS analytical platform for rAAV quantification and characterization.</name><description>Recombinant adeno-associated virus (rAAV)-based gene therapies are expanding in their application. Despite progress in manufacturing, current analytical methods for product quantification and characterization remain largely unchanged. Although critical for product and process development, in-process testing, and batch release, current analytical methods are labor-intensive, costly, and hampered by extended turnaround times and low throughput. The field requires more efficient, cost-effective analytical techniques capable of handling large sample quantities to accelerate product and process development. Here, we evaluated Stunner from Unchained Labs for quantifying and characterizing rAAVs and compared it with established analytical methods. Stunner is a combinatorial analytic technology pl</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-04T07:55:24.143Z</modification><creation>2025-04-04T07:55:24.143Z</creation></dates><accession>S-EPMC11338085</accession><cross_references><pubmed>39170800</pubmed><doi>10.1016/j.omtm.2024.101298</doi></cross_references></HashMap>